Genome-Wide Simplification of the AcMNPV Genome Using Synthetic Biology.

ACS Synth Biol

State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Large-scale genome simplification represents a fundamental goal in synthetic biology. Baculoviruses, with their biphasic life cycle and inherent genomic plasticity, have emerged as ideal models for synthetic genome engineering. Although modified baculovirus genomes are widely used as expression vectors for robust recombinant protein production, many genomic regions are dispensable for in vitro budded virus (BV) production. In this study, guided by the synthetic biology "design-build-test-learn" framework, we systematically reduced the genome of the Autographa californica multiple nucleopolyhedrovirus (AcMNPV) and obtained synthetic viruses capable of producing BVs. Building upon our previous work on whole-genome synthesis and partial genome reduction, we developed a strategy to rescue viruses by cotransfecting linearized genome fragments into host cells, thereby accelerating the iterative evaluation of genomic deletions. A total of 35 reduced genomes of varying sizes were synthesized, and the titers of the corresponding rescued viruses were measured. The most reduced functional genome, AcMNPV-Syn-mini, corresponds to the deletion of approximately 28 kb encompassing 39 nonessential genes. We analyze and discuss the gene organization and characteristics of this minimized genome. Our findings provide a foundation for the development of high-capacity baculoviral vectors and contribute to a deeper understanding of baculovirus functional genomics.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acssynbio.5c00156DOI Listing

Publication Analysis

Top Keywords

synthetic biology
12
genome
8
synthetic
5
genome-wide simplification
4
simplification acmnpv
4
acmnpv genome
4
genome synthetic
4
biology large-scale
4
large-scale genome
4
genome simplification
4

Similar Publications

Tilorone, a 9-fluorenone scaffold-based molecule, is a known broad-spectrum antiviral with an IC of 180 nM against SARS-CoV-2, but its mechanism is not known. In the present study, we found it to have weak activity against PLpro (IC = 30.7 ± 7.

View Article and Find Full Text PDF

Transcription factors (TFs) are essential proteins that regulate gene expression by specifically binding to transcription factor binding sites (TFBSs) within DNA sequences. Their ability to precisely control the transcription process is crucial for understanding gene regulatory networks, uncovering disease mechanisms, and designing synthetic biology tools. Accurate TFBS prediction, therefore, holds significant importance in advancing these areas of research.

View Article and Find Full Text PDF

Integrative Strategies Against Multidrug-Resistant Bacteria: Synthesizing Novel Antimicrobial Frontiers for Global Health.

Microb Pathog

September 2025

Central Research Laboratory and Molecular Diagnostics, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Sawangi (Meghe), Postal code 442001, Wardha, Maharashtra, India.

Concerningly, multidrug-resistant bacteria have emerged as a prime worldwide trouble, obstructing the treatment of infectious diseases and causing doubts about the therapeutic accidentalness of presently existing drugs. Novel antimicrobial interventions deserve development as conventional antibiotics are incapable of keeping pace with bacteria evolution. Various promising approaches to combat MDR infections are discussed in this review.

View Article and Find Full Text PDF

A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer.

Cell Chem Biol

September 2025

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China; Centre for Oncology and Im

RhoA is a key cancer driver and potential colorectal cancer (CRC) therapy target but remains undrugged clinically. Using activity-based protein profiling (ABPP) and mass spectrometry (MS), we identified CL16, a covalent inhibitor targeting the unique Cys16 on RhoA subfamily, which confers high specificity over other Rho family proteins. Cys16 is adjacent to the nucleotide-binding pocket and switch regions, which are critical for RhoA function.

View Article and Find Full Text PDF

Cancer is a complex and heterogeneous disease characterized by the accumulation of genetic and epigenetic alterations that drive uncontrolled cellular proliferation and survival. This review provides a comprehensive overview of key cancer driver genes, including oncogenes such as KRAS and PIK3CA, as well as tumor suppressor genes like TP53, PTEN, and CDKN2A, highlighting their molecular mechanisms and roles across various types of cancer. Leveraging insights from large-scale cancer genome initiatives and whole-genome sequencing, we examine the landscape of somatic mutations and their association with hallmark cancer pathways, including cell cycle regulation, apoptosis, metabolic reprogramming, and immune evasion.

View Article and Find Full Text PDF